Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: This session will explore how individuals will increasingly participate in personalized medicine and their own health care, from improved wellness to managing their personal heath data to partnering with researchers and physicians.
Session Chair Profile
S.B., MBA, Ph.D., Executive Chairman, Genos Research
Clifford A. Reid is a founder and Executive Chairman of Genos Research, a startup company that is creating a marketplace for genomics research. Previously he founded Complete Genomics, a human genome DNA sequencing company, where he served as Chairman and CEO from its inception in 2005 through its IPO in 2010 and its acquisition by BGI-Shenzhen in 2013. Prior to Complete Genomics, Dr. Reid founded Eloquent, Inc., a digital video communications company, where he served as Chairman and CEO from its inception in 1995 through its IPO in 2000 and acquisition in 2003. Prior to Eloquent, Dr. Reid founded Verity, Inc., an enterprise search engine company. He served as its Vice President of Engineering from its inception in 1988 to 1993. Dr. Reid received a S.B. in Physics from MIT, an MBA from the Harvard Business School, and a Ph.D. in Management Science and Engineering from Stanford University.
M.D., FCAP, Chief Medical Officer, Color Genomics
Most recently, Hagenkord served as senior vice president of medical strategy for InVitae Corporation, a genetics information company, where her role included serving as medical director, contributing to corporate strategy, acting as commercial liaison, and leading the company’s physician education programs. Hagenkord is a board-certified molecular genetic pathologist. Prior to joining Invitae, Jill served as chief medical officer and senior vice president at Complete Genomics, Inc. Her other prior experiences include founder and chief medical officer for iKaryos Diagnostics, associate professor of pathology at Creighton University School of Medicine, director of molecular pathology and clinical genomics at Creighton Medical Laboratories, and pathologist at Deltagen, Inc. Hagenkord received her M.D. from Stanford University School of Medicine in 1999, did her residency training in pathology at the University of California at San Francisco and the University of Iowa, and completed fellowships in pathology/oncology informatics and molecular genetic pathology at the University of Pittsburgh Medical Center.
Co-Founder, 23andMe, Curious, Inc.
Avey spent 20 years in sales and business development in biopharmaceuticals. Avey helped develop research programs for Affymetrix and Perlegen Sciences.In 2006, she co-founded the world’s first personal genetics service 23andMe with Paul Cusenza and Anne Wojcicki. In September 2009, Avey left 23andMe and started Brainstorm Research Foundation, focused on accelerating research in Alzheimer’s disease. In 2011, Avey co-founded Curious, Inc. with Mitsu Hadeishi and Heather Anne Halpert. “Curious is an open workspace we’re designing to help individuals answer questions about their well-being through personal data aggregation and discovery.